Litcius/Paper detail

Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations: A Database of 693 Cases

James Chih‐Hsin Yang, Martin Schüler, Sanjay Popat, Satoru Miura, Simon Heeke, Keunchil Park, Angela Märten, Edward S. Kim

2020Journal of Thoracic Oncology276 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAfatinibOncologyInternal medicineErlotinibEpidermal growth factor receptorCancerLung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesMelanoma and MAPK Pathways
Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations: A Database of 693 Cases | Litcius